Mashup Score: 1
PubMedLongitudinal analysis of patient experiences showed sustained benefits and preference for ide-cel up to 24 months after treatment. Trial Registration Number and Date: NCT03361748. December 5, 2017.
See more from Manni Mohyuddin
One of the things I prefer about CAR-T is the prolonged break patients get from continuous treatment. A small survey (subject to many severe biases with low completion rate/attrition) shows that patients prefer this too.